Previous research has linked TLR2 with polycystic ovary syndrome and metabolic comorbidities in obese women [53], with TLR2 mRNA levels increasing from early to mid-luteal phase [54]. This evidence concerns the gene TLR2 and polycystic ovary syndrome.